Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01219699
Title A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | GBR | ESP | DEU

Facility Status City State Zip Country Details
UCSF Medical Center San Francisco California 94143 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(4) Nashville Tennessee 37203 United States Details
Vanderbilt Univeristy SC Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center/University of Texas MD Anderson Houston Texas 77030-4009 United States Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Wuerzburg 97080 Germany Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Oxford OX3 7LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field